Ocugen Inc has a consensus price target of $5 based on the ratings of 5 analysts. The high is $8 issued by Roth Capital on June 15, 2022. The low is $2 issued by Cantor Fitzgerald on August 31, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Chardan Capital, and Chardan Capital on May 15, 2024, May 15, 2024, and April 22, 2024, respectively. With an average price target of $5.67 between HC Wainwright & Co., Chardan Capital, and Chardan Capital, there's an implied 233.33% upside for Ocugen Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/15/2024 | Buy Now | 311.76% | HC Wainwright & Co. | Swayampakula Ramakanth | → $7 | Reiterates | Buy → Buy | Get Alert |
05/15/2024 | Buy Now | 194.12% | Chardan Capital | Daniil Gataulin | $5 → $5 | Maintains | Buy | Get Alert |
04/22/2024 | Buy Now | 194.12% | Chardan Capital | Daniil Gataulin | $4 → $5 | Maintains | Buy | Get Alert |
04/03/2024 | Buy Now | 311.76% | HC Wainwright & Co. | Swayampakula Ramakanth | → $7 | Reiterates | Buy → Buy | Get Alert |
02/22/2024 | Buy Now | 311.76% | HC Wainwright & Co. | Swayampakula Ramakanth | → $7 | Reiterates | Buy → Buy | Get Alert |
01/24/2024 | Buy Now | 311.76% | HC Wainwright & Co. | Swayampakula Ramakanth | $5 → $7 | Maintains | Buy | Get Alert |
08/31/2023 | Buy Now | 17.65% | Cantor Fitzgerald | Jennifer Kim | $2.5 → $2 | Maintains | Overweight | Get Alert |
08/23/2023 | Buy Now | 194.12% | HC Wainwright & Co. | Swayampakula Ramakanth | → $5 | Reiterates | Buy → Buy | Get Alert |
05/08/2023 | Buy Now | 135.29% | Chardan Capital | Daniil Gataulin | $3.5 → $4 | Maintains | Buy | Get Alert |
04/17/2023 | Buy Now | 194.12% | HC Wainwright & Co. | Swayampakula Ramakanth | → $5 | Reiterates | → Buy | Get Alert |
04/14/2023 | Buy Now | 105.88% | Chardan Capital | Daniil Gataulin | → $3.5 | Maintains | Buy | Get Alert |
03/01/2023 | Buy Now | 105.88% | Chardan Capital | Daniil Gataulin | → $3.5 | Upgrade | Neutral → Buy | Get Alert |
03/01/2023 | Buy Now | 76.47% | Mizuho | Uy Ear | $5 → $3 | Maintains | Buy | Get Alert |
03/01/2023 | Buy Now | 194.12% | HC Wainwright & Co. | Swayampakula Ramakanth | $6 → $5 | Reiterates | → Buy | Get Alert |
08/23/2022 | Buy Now | 194.12% | Mizuho | Uy Ear | → $5 | Initiates | → Buy | Get Alert |
08/15/2022 | Buy Now | 252.94% | HC Wainwright & Co. | Swayampakula Ramakanth | $7 → $6 | Maintains | Buy | Get Alert |
06/15/2022 | Buy Now | 370.59% | Roth Capital | Jonathan Aschoff | → $8 | Reinstates | → Buy | Get Alert |
06/02/2022 | Buy Now | 164.71% | Cantor Fitzgerald | Jennifer Kim | → $4.5 | Initiates | → Overweight | Get Alert |
05/12/2022 | Buy Now | 311.76% | HC Wainwright & Co. | Swayampakula Ramakanth | $8 → $7 | Maintains | Buy | Get Alert |
02/28/2022 | Buy Now | 370.59% | HC Wainwright & Co. | Swayampakula Ramakanth | $10 → $8 | Maintains | Buy | Get Alert |
The latest price target for Ocugen (NASDAQ:OCGN) was reported by HC Wainwright & Co. on May 15, 2024. The analyst firm set a price target for $7.00 expecting OCGN to rise to within 12 months (a possible 311.76% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Ocugen (NASDAQ:OCGN) was provided by HC Wainwright & Co., and Ocugen reiterated their buy rating.
The last upgrade for Ocugen Inc happened on March 1, 2023 when Chardan Capital raised their price target to $3.5. Chardan Capital previously had a neutral for Ocugen Inc.
There is no last downgrade for Ocugen.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ocugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ocugen was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
While ratings are subjective and will change, the latest Ocugen (OCGN) rating was a reiterated with a price target of $7.00 to $7.00. The current price Ocugen (OCGN) is trading at is $1.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.